-
In the pharma industry, technology has become a mandate for some compliances
expresspharma
August 05, 2020
The importance of information technology and its potential to enhance the life sciences industry’s performance has been accentuated by the COVID-19 crisis.
-
Converge Biotech launches Vergiflu (favipiravir) for COVID-19 treatment
expresspharma
August 05, 2020
The product is available in all major hospitals across the country and will be sold only on prescription.
-
AXA Hong Kong, S.A.R., China launches additional coverage for COVID-19
prnasia
August 04, 2020
In light of the ongoing spread of the Coronavirus Disease 2019 (COVID-19), AXA Hong Kong, S.A.R., China is now offering the following enhanced coverage and services to its customers to give them a peace of mind.
-
Panchshil Realty's Office Portfolio First in APAC To Meet British Safety Council's Global Benchmarks for COVID-19 Related Control Measures
prnasia
August 04, 2020
Panchshil Realty and British Safety Council today announced a new milestone in workplace safety in the corporate real estate sector in India in the context of COVID-19 and safe return to work.
-
UK and US healthcare workers report higher rates of COVID-19 compared to general population in early pandemic period
worldpharmanews
August 04, 2020
The authors say that health-care systems should ensure adequate availability of PPE and develop additional strategies to protect health-care workers from COVID-19.
-
UK firm starts research on skin patch for COVID vaccines
pharmatimes
August 04, 2020
Innoture has received funding from the Welsh Government to start proof-of-concept research into the use of its next-generation microneedle skin patch for the self-administration of COVID-19 and other vaccines.
-
MHRA OKs Celltrion's Phase I trial of COVID drug
pharmatimes
August 04, 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a green light for a Phase I trial assessing Celltrion's potential COVID-19 treatment CT-P59.
-
Self-Contained, Rapid ADEXUSDx? COVID-19 Antibody Test Receives CE Mark
americanpharmaceuticalreview
August 04, 2020
NOWDiagnostics has received Conformité Européene (CE) mark approval for its ADEXUSDx? COVID-19 antibody test for use in moderate/complex laboratory settings across 28 countries in the European Union (EU).
-
ProMedica Researchers Observe Encouraging Outcomes with Allogeneic Stem Cells in COVID-19 Patients
americanpharmaceuticalreview
August 04, 2020
ProMedica announced promising results of its new study that evaluated the use of stem cells in the treatment of adult COVID-19 patients.
-
Global Trial for COVID-19 Vaccine Begins at NYU Langone Health
americanpharmaceuticalreview
August 04, 2020
The first U.S. patients are being dosed in a Phase 2/3 clinical trial testing whether a messenger RNA (mRNA) vaccine candidate can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).